| FOA |
Title |
Open Date |
Application Due Date |
| RFA-DK-20-022 |
Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional) |
Feb 3, 2021 |
Mar 3, 2021; Nov 17, 2021 |
| RFA-AI-20-057 |
Understanding the Role of the M. Tuberculosis Granuloma in Tuberculosis (TB) Disease and Treatment Outcomes (R01 Clinical Trial Not Allowed) |
Jan 22, 2021 |
Feb 22, 2021 |
| RFA-AI-20-055 |
Understanding Evolutionary Dynamics of Influenza to Inform and Improve Vaccine Strain Selection (R01 Clinical Trial Not Allowed) |
Jan 11, 2021 |
Feb 11, 2021 |
| RFA-MH-20-556 |
BRAIN Initiative: Pilot resources for brain cell type-specific access and manipulation across vertebrate species (U01 Clinical Trial Not Allowed) |
Jan 11, 2021 |
Feb 11, 2021; Oct 19, 2021 |
| PAR-20-295 |
Clinical Translation of Activated Optical Fluorescence Methods and Technologies for Sensitive Cancer Detection in Vivo (R01 Clinical Trial Optional) |
Jan 10, 2021 |
Feb 10, 2021; Oct 13, 2021 |
| RFA-AI-20-064 |
A Multidisciplinary Approach to Study Vaccine-elicited Immunity and Efficacy against Malaria (U01 Clinical Trial Not Allowed) |
Jan 8, 2021 |
Feb 8, 2021 |
| RFA-AI-20-060 |
Cohort Studies To Improve Our Understanding of Influenza Immunity, Vaccine Response and Effectiveness in Older Adults (65 years and older) (U01 Clinical Trial Not Allowed) |
Jan 4, 2021 |
Feb 4, 2021 |
| RFA-CA-20-043 |
Cancer Intervention and Surveillance Modeling Network (CISNET) Incubator Program for New Cancer Sites (U01 Clinical Trial Not Allowed) |
Dec 20, 2020 |
Jan 20, 2021 |
| RFA-MH-20-701 |
Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R01 Clinical Trial Not Allowed) |
Dec 8, 2020 |
Jan 8, 2021 |
| RFA-MH-20-702 |
Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R21 Clinical Trial Not Allowed) |
Dec 8, 2020 |
Jan 8, 2021 |
| RFA-CA-20-045 |
Limited Competition: International Agency for Research on Cancer (IARC) Monographs Program (R01 Clinical Trial Not Allowed) |
Nov 16, 2020 |
Dec 16, 2020 |
| RFA-CA-20-046 |
Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) |
Nov 13, 2020 |
Dec 15, 2020; Dec 14, 2021 |
| PAR-20-299 |
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) |
Nov 10, 2020 |
Dec 10, 2020;
Apr 9, 2021;
Aug 10, 2021;
Dec 10, 2021;
Apr 11, 2022;
Aug 10, 2022;
Dec 9, 2022 |
| PAR-20-300 |
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional) |
Nov 10, 2020 |
Dec 10, 2020;
Apr 9, 2021;
Aug 10, 2021;
Dec 10, 2021;
Apr 11, 2022;
Aug 10, 2022;
Dec 9, 2022 |
| RFA-HD-21-030 |
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed) |
Nov 10, 2020 |
Dec 10, 2020 |
| RFA-HD-21-006 |
Elucidating the Role of Nutrition in Care and Development of Preterm Infants (R01 Clinical Trial Optional) |
Oct 30, 2020 |
Nov 30, 2020 |
| PAR-20-273 |
New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial Required) |
Oct 18, 2020 |
Nov 8, 2020; Aug 11, 2021; Nov 18, 2021; Aug 11, 2022; Nov 18, 2022; August 11, 2023 |
| PAR-20-274 |
New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 – Clinical Trial Optional ) |
Oct 18, 2020 |
Nov 8, 2020; Aug 11, 2021; Nov 18, 2021; Aug 11, 2022; Nov 18, 2022; August 11, 2023 |
| PAR-20-294 |
Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed) |
Oct 12, 2020 |
Nov 12, 2020;
Apr 9, 2021;
Nov 9, 2021;
Apr 7, 2022;
Nov 9, 2022 |
| RFA-DE-21-001 |
Characterizing causal mechanisms to prevent dental fear and anxiety (R01 Basic Experimental Studies with Humans Required) |
Oct 10, 2020 |
Nov 10, 2020 |
| RFA-CA-20-034 |
NCI Pediatric In Vivo Testing Program (U01 Clinical Trial Not Allowed) |
Oct 9, 2020 |
Nov 9, 2020 |
| RFA-DA-21-013 |
Advancing HIV/AIDS Research through Computational Neuroscience FOA (R01 – Clinical Trial Optional) |
Oct 7, 2020 |
Nov 6, 2020 |
| PAR-20-284 |
Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed) |
Oct 4, 2020 |
Nov 4, 2020;
May 6, 2021;
Nov 4, 2021;
May 5, 2021;
Nov 3, 3022;
May 4, 2023 |
| RFA-HG-20-044 |
Defining Genomic Influence on Gene Network Regulation (U01 Clinical Trial Not Allowed) |
Oct 4, 2020 |
Nov 4, 2020 |
| RFA-HG-20-047 |
Developing Predictive Models of the Impact of Genomic Variation on Function (U01 Clinical Trial Not Allowed) |
Oct 4, 2020 |
Nov 4, 2020 |
| PAR-20-182 |
Large scale mapping and/or molecular profiling of ensembles and/or cell-types mediating opioid action in the rodent brain (R01 – Clinical Trial Not Allowed) |
Sep 30, 2020 |
Oct 30, 2020 |
| PAR-20-241 |
Large scale mapping and/or molecular profiling of ensembles and/or cell-types mediating opioid action in the rodent brain (R01 – Clinical Trial Not Allowed) |
Sep 30, 2020 |
Oct 30, 2020 |
| RFA-HG-20-048 |
Investigator-Initiated Research on Genetic Counseling Processes and Practices (R01 Clinical Trial Optional) |
Sep 28, 2020 |
Oct 28, 2020;
Jul 8, 2021 |
| RFA-HG-20-049 |
Investigator-Initiated Research on Genetic Counseling Processes and Practices (R21 Clinical Trial Optional) |
Sep 28, 2020 |
Oct 28, 2020;
Jul 8, 2021 |
| RFA-NS-21-006 |
Mechanisms of Pathological Spread of Abnormal Proteins in LBD and FTD (R01 Clinical Trial Not Allowed) |
Sep 27, 2020 |
Oct 27, 2020 |
| RFA-NS-21-007 |
Mechanisms of Selective Vulnerability in LBD and FTD (R01 Clinical Trial Not Allowed) |
Sep 27, 2020 |
Oct 27, 2020 |
| PAR-20-292 |
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) |
Sep 20, 2020 |
Oct 20, 2020; Feb 19, 2021; Jun 21, 2021; Oct 20, 2021; Feb 22, 2022; Jun 21, 2022 |
| PAR-20-254 |
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) |
Sep 19, 2020 |
Oct 19, 2020;
Feb 17, 2021;
Jun 17, 2021;
Oct 19, 2021;
Feb 17, 2022;
Jun 17, 2022;
Oct 19, 2022;
Feb 17, 2023;
Jun 19, 2023 |
| PAR-20-255 |
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) |
Sep 19, 2020 |
Oct 19, 2020;
Feb 17, 2021;
Jun 17, 2021;
Oct 19, 2021;
Feb 17, 2022;
Jun 17, 2022;
Oct 19, 2022;
Feb 17, 2023;
Jun 19, 2023 |
| PAR-20-281 |
Fertility Status as a Marker for Overall Health (R01 Clinical Trial Optional) |
Sep 19, 2020 |
Standard Dates |
| PAR-20-282 |
Fertility Status as a Marker for Overall Health (R21 Clinical Trial Not Allowed) |
Sep 19, 2020 |
Standard Dates |
| RFA-MH-20-500 |
Post-Acute Interventions for the Treatment of Anorexia Nervosa (R34 Clinical Trial Required) |
Sep 19, 2020 |
Oct 19, 2020 and
Jun 15, 2021 |
| PAR-20-264 |
Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed) |
Sep 16, 2020 |
Standard Dates |
| PAR-20-277 |
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) |
Sep 16, 2020 |
Standard Dates |
| RFA-DA-21-006 |
BRAIN Initiative: Tools for Germline Gene Editing in Marmosets (U01 – Clinical Trial Not Allowed) |
Sep 15, 2020 |
Oct 15, 2020;
Oct 14, 2021 |
| PAR-20-148 |
Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R21- Clinical Trial Not Allowed) |
Sep 13, 2020 |
Oct 13, 2020;
Mar 15, 2021;
Oct 13, 2021;
Mar 15, 2022;
Oct 13, 2022;
Mar 15, 2023 |
| RFA-AI-20-027 |
Mucosal Immunology Studies Team (MIST) (U01 Clinical Trial Not Allowed). |
Sep 9, 2020 |
Oct 9, 2020 |
| PAR-20-235 |
Behavioral Tasks Targeting Brain Systems Relevant to Anhedonia (R01 Basic Experimental Studies with Humans Required) |
Sep 5, 2020 |
Standard Dates |
| PAR-20-263 |
Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed) |
Sep 5, 2020 |
Standard Dates |
| PAR-20-271 |
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) |
Sep 5, 2020 |
Standard Dates |
| PAR-20-276 |
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) |
Sep 5, 2020 |
Standard Dates |
| RFA-AI-20-020 |
Tuberculosis Research Units (U19 Clinical Trial Optional) |
Aug 28, 2020 |
Sep 28, 2020 |
| RFA-CA-20-037 |
Tobacco Use and HIV in Low and Middle-Income Countries (U01 Clinical Trial Optional) |
Aug 24, 2020 |
Sep 24, 2020 |
| RFA-EB-20-002 |
BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed) |
Aug 14, 2020 |
Sep 14, 2020 |
| PA-20-149 |
HIV Infection of the Central Nervous System (R01 Clinical Trial Not Allowed) |
Aug 7, 2020 |
Standard Dates |
| PA-20-151 |
Eradication of HIV-1 from Central Nervous system Reservoirs (R01 Clinical Trial Not Allowed) |
Aug 7, 2020 |
Standard Dates |
| RFA-FD-21-001 |
Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01) Clinical Trials Required |
Aug 6, 2020,
Aug 5, 2021 |
Oct 6, 2020,
Oct 5, 2021 |
| RFA-EB-20-001 |
BRAIN Initiative: Proof of Concept Development of Early Stage Next Generation Human Brain Imaging (R01 Clinical Trial Not Allowed) |
Aug 3, 2020 |
Sep 3, 2020
and
Sep 3, 2021 |
| RFA-MH-20-128 |
BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed) |
Aug 3, 2020 |
Sep 3, 2020 and
Sep 2, 2021 |
| RFA-DA-21-005 |
Exploiting in vivo or in situ imaging approaches to understand HIV-relevant processes in the context of substance use disorders (R61/R33 Clinical Trials Optional) |
Jul 13, 2020 |
Aug 13, 2020 |
| RFA-FD-21-002 |
Renewal-Harmonization of Technical Requirements for Pharmaceuticals for Human Use (U01) Clinical Trials Not Allowed |
Jul 13, 2020 |
Oct 13, 2020 |
| RFA-AI-20-023 |
Limited Competition: International Epidemiology Databases to Evaluate AIDS (IeDEA) (U01 Clinical Trial Not Allowed) |
Jul 3, 2020 |
Aug 4, 2020 |
| RFA-HG-20-036 |
Advancing Genomic Medicine Research (R01 Clinical Trial Optional) |
Jul 3, 2020 |
Aug 3, 2020;
Mar 8, 2021;
Nov 2, 2021;
Aug 1, 2022;
Mar13, 2023 |
| RFA-HG-20-037 |
Advancing Genomic Medicine Research (R21 Clinical Trial Optional) |
Jul 3, 2020 |
Aug 3, 2020;
Mar 8, 2021;
Nov 2, 2021;
Aug 1, 2022;
Mar13, 2023 |
| RFA-CA-20-027 |
Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01 Clinical Trial Optional) |
Jun 30, 2020 |
Jul 31, 2020;
Jul 30, 2021 |
| RFA-CA-20-028 |
Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R21 Clinical Trial Optional) |
Jun 30, 2020 |
Jul 31, 2020;
Jul 30, 2021 |
| RFA-HD-21-005 |
Genomic Predictors of Pregnancy Loss (R01 Clinical Trial Not Allowed) |
Jun 30, 2020 |
Jul 30, 2020 |
| PAR-20-158 |
Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed) |
Jun 29, 2020 |
Jul 28, 2020;
Jul 28, 2021;
Jul 28, 2022 |
| RFA-AI-20-010 |
Advancing Vaccine Science to Improve Tuberculosis Treatment Outcomes for People Living With or Without HIV (R01 Clinical Trial Not Allowed) |
Jun 29, 2020 |
Jul 28, 2020 |
| RFA-AI-20-016 |
Harnessing Natural Killer (NK) Cells to Prevent, Control, or Eradicate HIV (R01 Clinical Trial Not Allowed) |
Jun 29, 2020 |
Jul 28, 2020 |
| PAR-20-120 |
Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD) |
Jun 28, 2020 |
Jul 28, 2020;
Mar 9, 2021;
Mar 9, 2022 |
| RFA-DA-21-004 |
Exploring the Roles of Biomolecular Condensates (BMCs) in HIV replication, latency, or pathogenesis in the context of substance use disorders (R21/R33 Clinical Trial Not Allowed) |
Jun 20, 2020 |
Jul 20, 2020 |
| PAR-20-108 |
International Research in Infectious Diseases (R01 Clinical Trial Not Allowed) |
Jun 15, 2020 |
Jul 15, 2020;
Jul 15, 2021;
Jul 15 2022 |
| RFA-DE-20-006 |
Defining Lineage Plasticity and Endogenous Regeneration Capacity of Dental, Oral, and Craniofacial Tissues (R01 Clinical Trial Not Allowed) |
Jun 8, 2020 |
Jul 8, 2020 |
| RFA-DE-20-007 |
Defining Lineage Plasticity and Endogenous Regeneration Capacity of Dental, Oral, and Craniofacial Tissues (R21 Clinical Trial Not Allowed) |
Jun 8, 2020 |
Jul 8, 2020 |
| RFA-AI-20-003 |
Partnerships for the Development of Universal Influenza Vaccines (R21/R33 Clinical Trial Not Allowed) |
Jun 2, 2020 |
Jul 2, 2020 |
| PAR-20-234 |
NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) |
Jun 1, 2020 |
Jul 1, 2020;
Aug 3, 2020;
Sep 1, 2020;
Oct 1, 2020;
Nov 2, 2020;
Dec 1, 2020;
Jan 4, 2021;
Feb 1, 2021 |
| RFA-AI-20-004 |
Molecular Mechanisms of Combination Adjuvants (MMCA) (U01 Clinical Trial Not Allowed) |
May 29, 2020 |
Jun 29, 2020 |
| RFA-HG-20-014 |
Novel Synthetic Nucleic Acid Technology Development (R01 Clinical Trial not allowed) |
May 25, 2020 |
Jun 24, 2020;
Feb 1, 2021;
Oct 1, 2021;
Jun 24, 2022 |
| RFA-HG-20-015 |
Novel Synthetic Nucleic Acid Technology Development (R21) (Clinical Trial not allowed) |
May 25, 2020 |
Jun 24, 2020;
Feb 1, 2021;
Oct 1, 2021;
Jun 24, 2022 |
| RFA-AI-20-008 |
Multidisciplinary Studies to Improve Understanding of Influenza Transmission (U19 Clinical Trial Optional) |
May 23, 2020 |
Jun 23, 2020 |
| RFA-HG-20-001 |
Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry – Study Sites (U01 Clinical Trial Not Allowed) |
May 23, 2020 |
Jun 23, 2020 |
| RFA-HG-20-002 |
Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry – Coordinating Center (U01 Clinical Trial Not Allowed) |
May 23, 2020 |
Jun 23, 2020 |
| RFA-AG-21-010 |
Glial Plasticity in the Aging Brain (R01 Clinical Trial Not Allowed) |
May 17, 2020 |
Jun 17, 2020 |
| PA-20-146 |
NIDA Small Research Grant Program (R03 Clinical Trial Required) |
May 16, 2020 |
Standard Dates |
| PA-20-194 |
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) |
May 16, 2020 |
Standard Dates |
| PA-20-195 |
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) |
May 16, 2020 |
Standard Dates |
| PA-20-196 |
NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required) |
May 16, 2020 |
Standard Dates |
| PA-20-200 |
NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) |
May 16, 2020 |
Standard Dates |
| PAR-20-140 |
Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed) |
May 16, 2020 |
Standard Dates |
| PAR-20-159 |
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer’s Dementia (R21 Clinical Trial Optional) |
May 16, 2020 |
Standard Dates |
| PAR-20-168 |
Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21 Clinical Trials Not Allowed) |
May 16, 2020 |
Standard Dates |
| RFA-AI-20-019 |
Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed |
May 15, 2020 |
Jun 15, 2020 |
| RFA-HL-21-007 |
Limited Competition: Sickle Pan-African Research Consortium Clinical Coordinating Center (U24 Clinical Trial Optional) |
May 8, 2020 |
Jun 8, 2020 |
| RFA-HL-21-008 |
Limited Competition: Sickle Africa Data Coordinating Center (U24 Clinical Trial Optional) |
May 8, 2020 |
Jun 8, 2020 |
| RFA-HL-21-009 |
Sickle Pan-African Research Consortium Collaborative Sites (U01 Clinical Trial Optional) |
May 8, 2020 |
Jun 8, 2020 |
| PA-20-183 |
Research Project Grant (Parent R01 Clinical Trial Required) |
May 5, 2020 |
Standard Dates |
| PA-20-184 |
Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required) |
May 5, 2020 |
Standard Dates |
| PA-20-185 |
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) |
May 5, 2020 |
Standard Dates |
| PAR-20-131 |
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) |
May 5, 2020 |
Standard Dates |
| PAR-20-137 |
In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed) |
May 5, 2020 |
Jun 5, 2020 (new) and Jul 5, 2020 (renewal, resubmission, revision);
Oct 5, 2020 (new) and Nov 5, 2020 (renewal, resubmission, revision);
Jun 5, 2021 (new) and Jul 5, 2021 (renewal, resubmission, revision);
Oct 5, 2021 (new) and Nov 5, 2021 (renewal, resubmission, revision);
Jun 5, 2022 (new) and Jul 5, 2022 (renewal, resubmission, revision);
Oct 5, 2022 (new) and Nov 5, 2022 (renewal, resubmission, revision) |
| PAR-20-155 |
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) |
May 5, 2020 |
Standard Dates |
| PAR-20-156 |
Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimer’s Disease (R01 Clinical Trial Optional) |
May 5, 2020 |
Standard Dates |
| PAR-20-157 |
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer’s Dementia (R01 Clinical Trial Optional) |
May 5, 2020 |
Standard Dates |
| PAR-20-165 |
Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R01 Clinical Trials Not Allowed) |
May 5, 2020 |
Standard Dates |
| PAR-20-177 |
Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) |
Apr 30, 2020 |
Applications will be accepted on a rolling basis,
beginning on Apr 30, 2020. |
| PAR-20-178 |
Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) |
Apr 30, 2020 |
Applications will be accepted on a rolling basis,
beginning on Apr 30, 2020. |
| RFA-FD-20-032 |
CBER FY20 FOA for AAV vector manufacturing for diseases affecting very small populations (R01) Clinical Trial Not Allowed |
Apr 22, 2020 |
Jun 23, 2020 |
| PAR-20-139 |
Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) |
Apr 13, 2020 |
May 13, 2020;
Sep 13, 2020;
Jan 13, 2021;
May 13, 2021;
Sep 13, 2021;
Jan 13, 2022;
May 13, 2022;
Sep 13, 2022;
Jan 13, 2023 |
| PAR-20-054 |
Transgender People: Immunity, Prevention, and Treatment (R21 Clinical Trial Not Allowed) |
Apr 10, 2020 |
May 11, 2020;
May 11, 2021 |
| PA-20-141 |
Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34 Clinical Trial Optional) |
Apr 7, 2020 |
Standard AIDS Dates |
| PA-20-144 |
Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional) |
Apr 7, 2020 |
Standard AIDS Dates |
| PA-20-145 |
Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional) |
Apr 7, 2020 |
Standard AIDS Dates |
| PAR-20-123 |
Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional) |
Apr 7, 2020 |
Standard AIDS Dates |
| PAR-20-127 |
Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional) |
Apr 7, 2020 |
Standard AIDS Dates |
| PAS-20-121 |
Research Towards Developing a Cure for HBV in HIV/HBV Co-Infection (R21 Clinical Trial Not Allowed) |
Apr 7, 2020 |
Standard AIDS Dates |
| RFA-FD-20-034 |
Cooperative Agreement to Support FDA Land and Water Initiative (U01) Clinical Trial Not Allowed |
Apr 1, 2020 |
Jun 1, 2020 |
| RFA-CA-20-005 |
Research Answers to National Cancer Institute’s (NCI) Provocative Questions (R21 Clinical Trial Optional) |
Mar 30, 2020 |
Apr 30, 2020;
Nov 17, 2020 |
| RFA-HG-20-008 |
Mendelian Genomics Data Coordinating Center (U24 Clinical Trial Not Allowed) |
Mar 16, 2020 |
Apr 15, 2020 |
| RFA-DK-19-036 |
Clinical Trials to Test Artificial Pancreas Device Systems in Populations Challenging to Manage Type 1 Diabetes (T1D) (U01 Clinical Trial Required) |
Mar 9, 2020 |
Apr 9, 2020 |
| PAR-20-136 |
Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed) |
Mar 7, 2020 |
Ap 7, 2020;
Nov 9, 2020;
Apr 9, 2021;
Nov 9, 2021;
Apr 7, 2022;
Nov 9, 2022 |
| RFA-DK-19-029 |
Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R01 Clinical Trial Optional) |
Mar 7, 2020 |
Apr 7, 2020 |
| RFA-AI-19-072 |
Novel Therapeutics Directed to Intracellular HIV Targets (R21 Clinical Trial Not Allowed) |
Mar 2, 2020 |
Apr 1, 2020 |
| RFA-DK-19-024 |
Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 Clinical Trial Not Allowed) |
Mar 1, 2020 |
Apr 1, 2020 |
| PAR-20-042 |
NCMRR Early Career Research Award (R03 Clinical Trial Optional) |
Feb 29, 2020 |
Mar 30, 2020;
Mar 30, 2021;
Mar 30, 2022 |
| RFA-DK-19-020 |
Mechanisms Underlying the Contribution of Type 1 Diabetes Disease-associated Variants (R01 Clinical Trial Not Allowed) |
Feb 26, 2020 |
Mar 26, 2020 |
| RFA-NS-20-006 |
BRAIN Initiative: Biology and Biophysics of Neural Stimulation and Recording Technologies (R01 Clinical Trials Optional) |
Feb 24, 2020 |
Mar 24, 2020,
Jun 2, 2020,
Oct 1, 2020,
Feb 2, 2021,
Jun 1, 2021,
Oct 1, 2021,
Feb 1, 2022,
Jun 1, 2022,
Oct 3, 2022 |
| RFA-CA-20-032 |
Radiobiology of High Linear Energy Transfer (High LET) Exposure in Cancer Treatment (R01, Clinical Trial Not Allowed) |
Feb 19, 2020 |
Mar 19, 2020 |
| RFA-AI-19-065 |
Understanding Phage Biology to Support the Development of Bacteriophage Therapy (R21 Clinical Trial Not Allowed) |
Feb 18, 2020 |
Feb 18, 2020 |
| RFA-FD-20-027 |
Integrated Pathogen Reduction Technologies for whole blood and blood components for transfusion (R01) Clinical Trial Not Allowed |
Feb 18, 2020 |
April 22, 2020 |
| PAR-19-373 |
Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Clinical Trials Not Allowed) |
Feb 17, 2020 |
Mar 17, 2020;
Mar 17, 2021 |
| PAR-19-384 |
Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Basic Experimental Studies with Humans Required) |
Feb 17, 2020 |
Mar 17, 2020;
Mar 17, 2021 |
| PAR-20-061 |
Co-infection and Cancer (R21 Clinical Trial Not Allowed) |
Feb 17, 2020 |
Mar 17, 2020;
Thereafter, Standard Dates Apply. |
| RFA-RM-20-003 |
Real Time Chromatin Dynamics and Function (U01 Clinical Trial Not Allowed) |
Feb 17, 2020 |
Mar 17, 2020 |
| RFA-RM-20-004 |
4DN Centers for Data Integration, Modeling and Visualization (UM1 Clinical Trial Not Allowed) |
Feb 17, 2020 |
Mar 17, 2020 |
| RFA-DA-20-022 |
Assessing the Effects of Cannabinoids on HIV-Induced Inflammation (R01 Clinical Trial Optional) |
Feb 11, 2020 |
Mar 11, 2020 |
| RFA-MH-20-330 |
Novel Imaging Approaches for detection of Persistent HIV and Neuroimmune dysfunction associated with HIV In the Central Nervous System (CNS) (R01 Clinical Trial Optional) |
Feb 11, 2020 |
Mar 11, 2020 |
| RFA-MH-20-331 |
Novel Imaging Approaches for detection of Persistent HIV and Neuroimmune dysfunction associated with HIV In the Central Nervous System (CNS) (R21 Clinical Trial Not Allowed) |
Feb 11, 2020 |
Mar 11, 2020 |
| PAR-19-373 |
Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Clinical Trials Not Allowed) |
Feb 10, 2020 |
Mar 17, 2020;
Mar 17, 2021 |
| PAR-19-384 |
Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Basic Experimental Studies with Humans Required) |
Feb 10, 2020 |
Mar 17, 2020;
Mar 17, 2021 |
| PAR-19-344 |
Explainable Artificial Intelligence for Decoding and Modulating Neural Circuit Activity Linked to Behavior (R01 Clinical Trial Optional) |
Feb 10, 2020 |
Mar 10, 2020;
Mar 10, 2021;
Mar 10, 2022 |
| PAR-20-062 |
Co-infection and Cancer (R01 Clinical Trial Not Allowed) |
Feb 6, 2020 |
Mar 06, 2020;
Thereafter, Standard Dates Apply. |
| RFA-MH-20-510 |
Laboratories to Optimize Digital Health (R01 Clinical Trial Required) |
Feb 2, 2020 |
Mar 2, 2020;
Nov 2, 2020 |
| RFA-RM-20-001 |
Transformative Technology Development for the Human BioMolecular Atlas Program (UG3/UH3 Clinical Trial Not Allowed) |
Feb 2, 2020 |
Mar 3, 2020 |
| RFA-RM-20-005 |
4DN Organization and Function in Human Health and Disease (U01 Clinical Trial Not Allowed) |
Feb 2, 2020 |
Mar 2, 2020 |
| PAR-20-074 |
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed) |
Jan 28, 2020 |
Feb 28, 2020;
Jul 10, 2020;
Oct 27, 2020;
Feb 26, 2021;
Jul 13, 2021;
Oct 26, 2021;
Feb 28, 2022;
Jul 11, 2022;
Oct 28, 2022 |
| RFA-MH-21-100 |
Fine-Mapping Genome-Wide Associated Loci to Identify Proximate Causal Mechanisms of Serious Mental Illness (R01 Clinical Trial Not Allowed) |
Jan 28, 2020 |
Feb 28, 2020 |
| PAR-20-078 |
Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed) |
Jan 26, 2020 |
Feb 26, 2020,
Oct 28, 2020,
Feb 26, 2021,
Oct 28, 2021,
Feb 26, 2022,
Oct 28, 2022 |
| RFA-CA-20-017 |
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) |
Jan 21, 2020 |
Feb , 2020;
May 28, 2020;
Sep 29, 2020 |
| RFA-CA-20-018 |
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) |
Jan 21, 2020 |
Feb , 2020;
May 28, 2020;
Sep 29, 2020 |
| RFA-CA-20-019 |
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) |
Jan 21, 2020 |
Feb , 2020;
May 28, 2020;
Sep 29, 2020 |
| RFA-CA-20-020 |
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) |
Jan 21, 2020 |
Feb , 2020;
May 28, 2020;
Sep 29, 2020 |
| RFA-CA-20-021 |
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) |
Jan 21, 2020 |
Feb , 2020;
May 28, 2020;
Sep 29, 2020 |
| RFA-CA-20-022 |
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) |
Jan 21, 2020 |
Feb , 2020;
May 28, 2020;
Sep 29, 2020 |
| PAR-20-083 |
Enhancing Regulatory Science for Advancing Pharmaceutical Quality and Manufacturing (U01) Clinical Trials Optional |
Jan 10, 2020 for Apr 10, 2020 Application Due Date for All Subsequent Application Due Dates,
the Earliest Submission Date will be 90 Days Prior to the Application Due Date. |
Apr 10, 2020, by 11:59 PM Eastern Time.
Apr 3, 2021, by 11:59 PM Eastern Time.
Apr 2, 2022, by 11:59 PM Eastern Time. |
| RFA-RM-19-012 |
Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed) |
Jan 19, 2020 |
Feb 19, 2020 |
| PAR-19-375 |
Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed) |
Jan 16, 2020 |
Standard Dates |
| PAR-19-389 |
Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional) |
Jan 16, 2020 |
Standard Dates |
| PAR-20-046 |
NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed) |
Jan 16, 2020 |
Standard Dates |
| PAR-20-065 |
Small Research Grants for Establishing Basic Science-Clinical Collaborations to Understand Structural Birth Defects (R03 Clinical Trial Not Allowed) |
Jan 16, 2020 |
Standard Dates |
| PAR-20-082 |
Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed) |
Jan 16, 2020 |
Standard Dates |
| PAS-19-391 |
Small Research Grant Program for the Next Generation of Clinical Researchers in AD/ADRD Research: Area of Focus Archiving and Leveraging Existing Data Sets for Analyses (R03 Clinical Trial Not Allowed) |
Jan 16, 2020 |
Standard Dates |
| PAS-19-392 |
Small Research Grant Program for the Next Generation of Clinical Researchers in AD/ADRD Research: Area of Focus Basic Science (R03 Clinical Trials Not Allowed) |
Jan 16, 2020 |
Standard Dates |
| PAS-19-393 |
Small Research Grant Program for the Next Generation of Clinical Researchers in AD/ADRD Research: Area of Focus Systems Biology (R03 Clinical Trial Not Allowed) |
Jan 16, 2020 |
Standard Dates |
| PAR-20-026 |
Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations (U01 Clinical Trial Not Allowed) |
Jan 15, 2020 |
Feb 14, 2020;
Sep 15, 2020;
Sep 15, 2021;
Sep 15, 2022 |
| PAR-20-027 |
Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations (Collaborative U01 Clinical Trial Not Allowed) |
Jan 15, 2020 |
Feb 14, 2020;
Sep 15, 2020;
Sep 15, 2021;
Sep 15, 2022 |
| RFA-MH-20-326 |
Dysregulation and Proximal Risk for Suicide (R21 Clinical Trial Optional) |
Jan 13, 2020 |
Feb 13, 2020 |
| RFA-MH-20-327 |
Dysregulation and Proximal Risk for Suicide (R01 Clinical Trial Optional) |
Jan 13, 2020 |
Feb 13, 2020 |
| RFA-OD-19-028 |
Tobacco Regulatory Science (R01 Clinical Trial Optional) |
Jan 13, 2020 |
Feb 13, 2020
Jul 17, 2020
Feb 13, 2021 |
| RFA-MH-20-305 |
Addressing Suicide Research Gaps: Understanding Mortality Outcomes (R01 Clinical Trial Not Allowed ) |
Jan 10, 2020 |
Feb 10, 2020 |
| RFA-MH-20-320 |
Identification, Validation, and Manipulation of Neural Circuits Related to Mental Illness and Alcohol and Substance Use Disorders in Non-human Primates (R01 Clinical Trial Not Allowed) |
Jan 10, 2020 |
Feb 10, 2020 |
| RFA-MH-20-350 |
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional) |
Jan 10, 2020 |
Feb 10, 2020;
Oct 9, 2020;
Jun 10, 2021 |
| RFA-MH-20-351 |
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional) |
Jan 10, 2020 |
Feb 10, 2020;
Oct 9, 2020;
Jun 10, 2021 |
| PAR-20-037 |
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed) |
Jan 8, 2020 |
Standard Dates |
| PAR-20-038 |
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional) |
Jan 8, 2020 |
Standard Dates |
| RFA-TR-20-001 |
Ethical Issues in Translational Science Research (R01 Clinical Trial Optional) |
Jan 6, 2020 |
Feb 6, 2020;
Oct 6, 2020;
Oct 6, 2021 |
| PAR-19-377 |
Omics-guided Biobehavioral Interventions for Improved Health Outcomes: A Step Forward in Translation (R01 Clinical Trial Optional) |
Jan 5, 2020 |
Standard Dates |
| PAR-19-387 |
Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional) |
Jan 5, 2020 |
Standard Dates |
| PAR-20-034 |
Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01 Clinical Trial Optional) |
Jan 5, 2020 |
Standard Dates
(The first standard due date for this FOA is February 5, 2020.) |
| PAR-20-045 |
NIDCR Research Grants for Analyses of Existing Genomics Data (R01 Clinical Trial Not Allowed) |
Jan 5, 2020 |
Standard Dates |
| PAR-20-053 |
Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection (R01 Clinical Trial Not Allowed) |
Jan 5, 2020 |
Standard Dates |
| PAR-20-055 |
Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed) |
Jan 5, 2020 |
Standard Dates |
| RFA-AG-20-016 |
Lucidity in Dementia (R21 Clinical Trial Optional) |
Jan 3, 2020 |
Feb 3, 2020 |
| RFA-AG-20-027 |
Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not Allowed) |
Jan 3, 2020 |
Feb 3, 2020 |
| RFA-AG-20-037 |
Dementia Care: Home- and Community-Based Services (HCBS) (R01 Clinical Trial Not Allowed) |
Jan 3, 2020 |
Feb 3, 2020 |
| RFA-AG-20-038 |
Dementia Care: Home- and Community-Based Services (HCBS) (R21 Clinical Trial Not Allowed) |
Jan 3, 2020 |
Feb 3, 2020 |
| RFA-AG-20-039 |
Lipid Signaling in Healthspan and Longevity Regulation (R01 Clinical Trial Not Allowed) |
Jan 3, 2020 |
Jan 3, 2020 |
| RFA-AG-20-017 |
Lucidity in Dementia (R21/R33 Clinical Trial Optional) |
Jan 3, 2020 |
Feb 3, 2020 |
| RFA-MH-20-340 |
Clinical High Risk for Psychosis Research Network (U01 Clinical Trial Not Allowed) |
Dec 31, 2019 |
Jan 31, 2020 |
| RFA-AG-20-036 |
Biology of Aging in Reproductive Tissues (R01 Clinical Trial Not Allowed) |
Dec 29, 2019 |
Jan 29, 2020 |
| RFA-FD-20-018 |
Physiologically-based pharmacokinetic/pharmacodynamic model extrapolation to human from rabbit for ophthalmic drug products (U01) Clinical Trials Not Allowed |
Dec 26, 2019 |
Feb 27, 2020 |
| RFA-FD-20-019 |
Bioequivalence of Topical Products: Elucidating Fundamental Principles of Dermal Pharmacokinetics for Microdialysis or Microperfusion Techniques (U01) Clinical Trials Not Allowed |
Dec 19, 2019 |
Feb 27, 2020 |
| RFA-AI-19-059 |
Accelerating Discovery of Efficacious Pre-erythrocytic Stage Malaria Vaccines (U01 Clinical Trial Not Allowed) |
Dec 17, 2019 |
Jan 17, 2020 |
| RFA-DA-20-026 |
Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed) |
Dec 15, 2019 |
Jan 15, 2020 |
| PAR-19-307 |
Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01 Clinical Trial Not Allowed) |
Dec 13, 2019 |
Jan 14, 2020;
Jan 14, 2021;
Jan 14, 2022 |
| PAR-20-029 |
Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01 Clinical Trial Not Allowed) |
Dec 6, 2019 |
Jan 7, 2020;
Jan 7, 2021;
Jan 7, 2022 |
| PAR-20-031 |
Human-Animal Interaction (HAI) Research (R01 Clinical Trial Optional) |
Nov 20, 2019 |
Dec 20, 2019;
Nov 30, 2020;
Nov 30, 2021 |
| PAR-20-032 |
Human-Animal Interaction (HAI) Research (R03 Clinical Trial Optional) |
Nov 20, 2019 |
Dec 20, 2019;
Nov 30, 2020;
Nov 30, 2021 |
| PAR-20-033 |
Human-Animal Interaction (HAI) Research (R21 Clinical Trial Optional) |
Nov 20, 2019 |
Dec 20, 2019;
Nov 30, 2020;
Nov 30, 2021 |
| PAR-20-030 |
HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional) |
Nov 15, 2019 |
Dec 15, 2019;
Dec 3, 2020 |
| PAR-19-376 |
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 – Clinical Trial Optional) |
Oct 14, 2019 |
Nov 19, 2019;
Sep 24, 2020 |
| PAR-19-361 |
Small Cell Lung Cancer (SCLC) Consortium: Biology, Therapy and Resistance (U01 Clinical Trial Not Allowed) |
Oct 12, 2019 |
Nov 12, 2019;
Mar 11, 2020;
Nov 12, 2020;
Mar 11, 2021;
Nov 12, 2021;
Mar 11, 2022 |
| PAR-19-353 |
Neural Regulation of Cancer (R01 Clinical Trial Not Allowed) |
Sep 21, 2019 |
Oct 21, 2019;
May 27, 2020;
Oct 21, 2020;
May 27, 2021;
Oct 21, 2021;
May 27, 2022 |
| PAR-19-354 |
Neural Regulation of Cancer (R21 Clinical Trial Not Allowed) |
Sep 21, 2019 |
Oct 21, 2019;
May 27, 2020;
Oct 21, 2020;
May 27, 2021;
Oct 21, 2021;
May 27, 2022 |
| PAR-19-356 |
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) |
Sep 18, 2019 |
Oct 18, 2019;
Feb 20, 2020;
Jun 19, 2020;
Oct 20, 2020;
Feb 19, 2021;
Jun 21, 2021;
Oct 20, 2021;
Feb 22, 2022;
Jun 21, 2022 |
| PAR-19-309 |
Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional) |
Sep 16, 2019 |
Standard Dates |
| PAR-19-311 |
Mechanisms of Tolerance (R21/R33 – Clinical Trial Required) |
Sep 16, 2019 |
Standard Dates |
| PAR-19-346 |
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R21 Clinical Trial Not Allowed) |
Sep 16, 2019 |
Standard Dates |
| PAR-19-370 |
NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed) |
Sep 16, 2019 |
Standard Dates |
| PAR-19-339 |
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional) |
Sep 9, 2019 |
Oct 9, 2019;
Jun 10, 2020;
Oct 14, 2020;
Jun 9, 2021;
Oct 13, 2021;
Jun 8, 2022 |
| PAR-19-340 |
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional) |
Sep 9, 2019 |
Oct 9, 2019;
Jun 10, 2020;
Oct 14, 2020;
Jun 9, 2021;
Oct 13, 2021;
Jun 8, 2022 |
| RFA-OD-19-021 |
Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed) |
Sep 9, 2019 |
Oct 8, 2019;
Aug 7, 2020;
Mar 8, 2021 |
| RFA-OD-19-022 |
Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed) |
Sep 9, 2019 |
Oct 8, 2019;
Jul 20, 2020;
Mar 8, 2021 |
| PAR-19-269 |
Cognitive Systems Analysis of Alzheimer’s Disease Genetic and Phenotypic Data (U01 Clinical Trial Not Allowed) |
Sep 5, 2019 |
Standard Dates |
| PAR-19-297 |
Clinical Studies of Mental Illness (Collaborative R01 Clinical Trial Optional) |
Sep 5, 2019 |
Standard Dates |
| PAR-19-298 |
Non-Invasive Neurostimulation in AD/ADRD (R01 Clinical Trial Optional) |
Sep 5, 2019 |
Standard Dates |
| PAR-19-289 |
Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) |
Sep 5, 2019 |
Standard Dates |
| PAR-19-302 |
NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) |
Sep 5, 2019 |
Standard Dates |
| PAR-19-368 |
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) |
Sep 5, 2019 |
Standard Dates |
| PAR-19-325 |
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) |
Aug 30, 2019 |
Sep 30, 2019;
Feb 11, 2020;
Sep 30, 2020;
Feb 11, 2021;
Sep 20, 2021;
Feb 11, 2022 |
| RFA-MH-20-135 |
BRAIN Initiative: Tools to Facilitate High-Throughput Microconnectivity Analysis (R01 Clinical Trial Not Allowed) |
Aug 27, 2019 |
Sep 27, 2019 and
Sep 30, 2020 |
| RFA-MH-20-120 |
BRAIN Initiative: Secondary Analysis and Archiving of BRAIN Initiative Data (R01 Clinical Trial Not Allowed) |
Aug 6, 2019 |
Sep 6, 2019 and
Jun 11, 2020 |
| RFA-EB-19-002 |
BRAIN Initiative: Development of Next Generation Human Brain Imaging Tools and Technologies (U01 Clinical Trial Not Allowed) |
Aug 3, 2019 |
Sep 3, 2019;
Sep 3, 2020;
Sep 3, 2021 |
| RFA-MH-20-310 |
BRAIN Initiative: Non-Invasive Neuromodulation – New Tools and Techniques for Spatiotemporal Precision (R01 Clinical Trial Optional) |
Aug 3, 2019 |
Sep 3, 2019;
Feb 14, 2020 |
| PAR-19-220 |
Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed) |
Jul 14, 2019 |
Aug 14, 2019;
Feb 19, 2020;
Aug 19, 2020;
Feb 17, 2021;
Aug 18, 2021;
Feb 16, 2022 |
| PAR-19-212 |
Behavioral & Integrative Treatment Development Program (R01 Clinical Trial Optional) |
Jun 23, 2019 |
Jul 23, 2019;
Mar 23, 2020;
Jul 23, 2020;
Mar 23, 2021;
Jul 23, 2021;
Mar 23, 2022 |
| PAR-19-213 |
Behavioral & Integrative Treatment Development Program (R34 Clinical Trial Optional) |
Jun 23, 2019 |
Jul 23, 2019;
Mar 23, 2020;
Jul 23, 2020;
Mar 23, 2021;
Jul 23, 2021;
Mar 23, 2022 |
| RFA-AI-19-030 |
Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (U01 Clinical Trial Not Allowed) |
Jun 21, 2019 |
Jul 22, 2019 |
| RFA-OD-19-019 |
Tobacco Regulatory Science (R01 Clinical Trial Optional) |
Jun 19, 2019 |
Jul 19, 2019;
Feb 13, 2020;
Jul 17, 2020;
Feb 13, 2021 |
| PAR-19-287 |
Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional) |
Jun 15, 2019 |
Jul 15, 2019;
Nov 15, 2019;
Jul 10, 2020;
Nov 17, 2020;
Jul 9, 2021;
Nov 15, 2021 |
| PAR-19-264 |
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01 Clinical Trial Optional) |
Jun 10, 2019 |
Jul 10, 2019;
Dec 10, 2019;
Jul 10, 2020;
Dec 10, 2020;
Jul 9, 2021;
Dec 10, 2021 |
| PAR-19-251 |
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R01 Clinical Trial Optional) |
Jun 2, 2019 |
Jul 2, 2019;
Nov 6, 2019;
Jul 2, 2020;
Nov 6, 2020;
Jul 8, 2021;
Nov 8, 2021 |
| PAR-19-252 |
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R21 Clinical Trial Optional) |
Jun 2, 2019 |
Jul 2, 2019;
Nov 6, 2019;
Jul 2, 2020;
Nov 6, 2020;
Jul 8, 2021;
Nov 8, 2021 |
| PAR-19-261 |
Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed) |
Jun 1, 2019 |
Jul 1, 2019;
Dec 16, 2019;
May 1, 2020;
Dec 15, 2020;
May 3, 2021;
Dec 13, 2021 |
| PAR-19-279 |
Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R01 Clinical Trial Optional) |
30 days after
May 13, 2019 |
Jul 15, 2019;
Nov 15, 2019;
Jul 15, 2020;
Nov 15, 2020 |
| PAR-19-280 |
Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R21 Clinical Trial Optional) |
30 days after
May 13, 2019 |
Jul 15, 2019;
Nov 15, 2019;
Jul 15, 2020;
Nov 15, 2020 |
| PAR-19-247 |
Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination (R21 Clinical Trial Not Allowed) |
May 18, 2019 |
Jun 18, 2019;
Jun 18, 2020;
Jun 18, 2021 |
| PA-19-237 |
Novel RNAs in Virology (including HIV) and Immune Regulation: Basic Science and Therapeutic Discovery (R21 Clinical Trial Not Allowed) |
May 16, 2019 |
Standard Dates |
| PAR-19-163 |
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed) |
May 16, 2019 |
Standard Dates |
| PAR-19-173 |
Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R21 Clinical Trial Not Allowed) |
May 16, 2019 |
Standard Dates |
| PAR-19-184 |
Biology of Bladder Cancer (R21 Clinical Trial Optional) |
May 16, 2019 |
Standard Dates |
| PAR-19-194 |
Microbial-based Cancer Therapy – Bugs as Drugs (R21 Clinical Trial Not Allowed) |
May 16, 2019 |
Standard Dates |
| PAR-19-231 |
NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed) |
May 16, 2019 |
Standard Dates |
| PAR-19-260 |
NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed) |
May 16, 2019 |
Standard Dates |
| PAR-19-275 |
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) |
May 16, 2019 |
Standard Dates |
| PAR-19-276 |
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) |
May 16, 2019 |
Standard Dates |
| RFA-CA-19-038 |
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) |
May 11, 2019 |
Jun 11, 2020;
Nov 20 2020 |
| RFA-CA-19-039 |
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) |
May 11, 2019 |
Jun 11, 2020;
Nov 20 2020 |
| RFA-CA-19-040 |
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) |
May 11, 2019 |
Jun 11, 2020;
Nov 20 2020 |
| RFA-CA-19-041 |
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) |
May 11, 2019 |
Jun 11, 2020;
Nov 20 2020 |
| PAR-19-198 |
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed) |
May 10, 2019 |
Jun 10, 2019;
Nov 6, 2019;
Jun 10, 2020;
Nov 6 2020;
Jun 10, 2021;
Nov 8, 2021 |
| PAR-19-199 |
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed) |
May 10, 2019 |
Jun 10, 2019;
Nov 6, 2019;
Jun 10, 2020;
Nov 6 2020;
Jun 10, 2021;
Nov 8, 2021 |
| PAR-19-248 |
Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination (R01 Clinical Trial Not Allowed) |
May 10, 2019 |
Jun 10, 2019;
Jun 10, 2020;
Jun 10,2021 |
| PAR-19-274 |
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) |
May 8, 2019 |
Standard Dates |
| PAR-19-277 |
Exploratory Grants in Cancer Epidemiology (R21 Clinical Trial Optional) |
May 8, 2019 |
Jun 7, 2019;
Oct 8, 2019;
Jun 8, 2020;
Oct 8, 2020;
Jun 8, 2021;
Oct 8, 2021 |
| PAR-19-183 |
Biology of Bladder Cancer (R01 Clinical Trial Optional) |
May 5, 2019 |
Standard Dates |
| PAR-19-193 |
Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed) |
May 5, 2019 |
Standard Dates |
| PAR-19-162 |
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) |
May 5, 2019 |
Standard Dates |
| PAR-19-172 |
Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R01 Clinical Trial Not Allowed) |
May 5, 2019 |
Standard Dates |
| PAR-19-234 |
Limited Competition: Additional Sequencing for the Alzheimer’s Disease Sequencing Project (U01 Clinical Trial Not Allowed) |
May 5, 2019 |
Standard Dates |
| PAS-19-210 |
Progression Markers for Cognitive Impairment in Parkinson’s Disease Dementia (R01 Clinical Trial Not Allowed) |
May 5, 2019 |
Standard Dates |
| PAR-19-209 |
Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional) |
Apr 6, 2019 |
May 6, 2019;
May 6, 2020;
May 6, 2021 |
| RFA-MH-20-110 |
Secondary Data Analysis to Examine Long-Term and/or Potential Cross-Over Effects of Prevention Interventions: What are the Benefits for Preventing Mental Health Disorders? (R01 Clinical Trial Not Allowed) |
Apr 2, 2019 |
May 2, 2019;
Jan 2, 2020 |
| PAR-18-951 |
Functional RNA Modifications Environment and Disease (FRAMED) (R01 Clinical Trial Not Allowed) |
Mar 15, 2019 |
Apr 15, 2019;
Apr 15, 2020;
Apr 15, 2021 |
| PAR-19-190 |
Advancing Post-Market Surveillance of High-Risk Facilities and Products through Signal detection, Data analysis, and the Review of the State of Quality (U01) Clinical Trial Optional |
Mar 1, 2019 |
May 1, 2019, by 11:59 PM Eastern Time.
Apr 4, 2020, by 11:59 PM Eastern Time.
Apr 5, 2021, by 11:59 PM Eastern Time. |
| RFA-CA-19-033 |
Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required) |
Feb 15, 2019 |
Mar 15, 2019;
and Jan 3, 2020 |
| PAR-19-070 |
Research on Current Topics in Alzheimer’s Disease and Its Related Dementias (R01 Clinical Trial Optional) |
Feb 11, 2019 |
Mar 11, 2019;
Jul 9, 2019;
Nov 12, 2019;
Mar 11, 2020;
Jul 9, 2020;
Nov 12, 2020;
Mar 11, 2021;
Jul 9, 2021;
and Nov 12, 2021 |
| PAR-19-071 |
Research on Current Topics in Alzheimer’s Disease and Its Related Dementias (R21 Clinical Trial Not Allowed) |
Feb 11, 2019 |
Mar 11, 2019;
Jul 9, 2019;
Nov 12, 2019;
Mar 11, 2020;
Jul 9, 2020;
Nov 12, 2020;
Mar 11, 2021;
Jul 9, 2021;
and Nov 12, 2021 |
| PA-18-939 |
Research on Chronic Overlapping Pain Conditions (R21 Clinical Trial Not Allowed) |
Jan 16, 2019 |
Standard Dates |
| PA-18-943 |
Biobehavioral Basis of Chronic Pain (R21 Clinical Trial Optional) |
Jan 16, 2019 |
Standard Dates |
| PA-18-944 |
Biobehavioral Basis of Chronic Pain (R01 Clinical Trial Optional) |
Jan 16, 2019 |
Standard Dates |
| PA-18-946 |
Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R21 Clinical Trial Optional) |
Jan 16, 2019 |
Standard Dates |
| PA-19-020 |
Fc-Dependent Mechanisms of Antibody-Mediated Killing (R21 Clinical Trial Not Allowed) |
Jan 16, 2019 |
Standard Dates |
| PA-19-024 |
Addressing Caregiver Symptoms through Technological Tools (R21 Clinical Trial Optional) |
Jan 16, 2019 |
Standard Dates |
| PA-19-046 |
Advancing Research in Augmentative and Alternative Communication (AAC) (R21 Clinical Trial Optional) |
Jan 16, 2019 |
Standard Dates |
| PA-19-053 |
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) |
Jan 16, 2019 |
Standard Dates |
| PA-19-054 |
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) |
Jan 16, 2019 |
Standard Dates |
| PA-19-066 |
Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowed) |
Jan 16, 2019 |
Standard Dates |
| PA-19-068 |
Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21 Clinical Trial Not Allowed) |
Jan 16, 2019 |
Standard Dates |
| PA-19-073 |
Telomeres in Wellness and Disease: A Biobehavioral Approach (R21 Clinical Trial Optional) |
Jan 16, 2019 |
Standard Dates |
| PA-19-081 |
Advancing Development of Rapid Fungal Diagnostics (R21 Clinical Trial Not Allowed) |
Jan 16, 2019 |
Standard Dates |
| PA-19-092 |
NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required) |
Jan 16, 2019 |
Standard Dates |
| PA-19-095 |
Emotion Regulation, Aging and Mental Disorder (R01 Clinical Trial Not Allowed) |
Jan 16, 2019 |
Standard Dates |
| PA-19-111 |
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional) |
Jan 16, 2019 |
Standard Dates |
| PAR-19-147 |
Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed) |
Jan 16, 2019 |
Standard Dates |
| PAR-19-146 |
Drug Discovery For Nervous System Disorders (R21 Clinical Trial Not Allowed) |
Jan 16, 2019 |
Standard Dates |
| PAR-19-058 |
Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals (R21 Clinical Trial Optional) |
Jan 16, 2019 |
Standard Dates |
| PAR-19-069 |
Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03 – Clinical Trial Not Allowed) |
Jan 16, 2019 |
Standard Dates |
| PAR-19-079 |
Molecular and Genetic Characterization of Inborn Errors of Immunity (R21 Clinical Trial Not Allowed) |
Jan 16, 2019 |
Standard Dates |
| PAR-18-913 |
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) |
Jan 11, 2019 |
Feb 11, 2019;
Aug 14, 2019;
Feb 11, 2020;
Aug 11, 2020 |
| PAR-19-159 |
Bioengineering Research Grants (BRG) (R01 Clinical Trial Required) |
Jan 8, 2019 |
Standard Dates |
| PAR-19-158 |
Bioengineering Research Grants (BRG) (R01 Clinical Trial Required) |
Jan 8, 2019 |
Standard Dates |
| PAR-19-157 |
Bioengineering Research Partnerships (U01 Clinical Trial Required) |
Jan 8, 2019 |
Standard Dates |
| PAR-19-156 |
Bioengineering Research Partnerships (U01 Clinical Trial Not Allowed) |
Jan 8, 2019 |
Standard Dates |
| PAR-19-153 |
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional) |
Jan 8, 2019 |
Standard Dates |
| PAR-19-150 |
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) |
Jan 8, 2019 |
Standard Dates |
| PAR-19-149 |
Exploratory/Developmental Bioengineering Research Grants(EBRG) (R21 Clinical Trial Not Allowed) |
Jan 8, 2019 |
Standard Dates |
| PA-19-077 |
Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed) |
Jan 6, 2019 |
Standard Dates |
| PAR-19-113 |
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) |
Jan 5, 2019 |
Standard Dates |
| PAS-19-097 |
Research to Advance HBV Cure: HIV/HBV Co-Infection and HBV Mono-infection (R01 Clinical Trial Not Allowed) |
Jan 5, 2019 |
Standard AIDS Dates |
| PA-18-907 |
New Computational Methods for Understanding the Functional Role of DNA Variants that are Associated with Mental Disorders (R01 (Collab) Clinical Trial Not Allowed) |
Jan 5, 2019 |
Standard Dates |
| PA-18-908 |
New Computational Methods for Understanding the Functional Role of DNA Variants that are Associated with Mental Disorders (R01 Clinical Trial Not Allowed) |
Jan 5, 2019 |
Standard Dates |
| PA-18-937 |
Research on Chronic Overlapping Pain Conditions (R01 Clinical Trial Optional) |
Jan 5, 2019 |
Standard Dates |
| PA-18-945 |
Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R01 Clinical Trial Optional) |
Jan 5, 2019 |
Standard Dates |
| PA-19-023 |
Addressing Caregiver Symptoms through Technological Tools (R01 Clinical Trial Optional) |
Jan 5, 2019 |
Standard Dates |
| PA-19-047 |
Advancing Research in Augmentative and Alternative Communication (AAC) (R01 Clinical Trial Optional) |
Jan 5, 2019 |
Standard Dates |
| PA-19-055 |
Research Project Grant (Parent R01 Clinical Trial Required) |
Jan 5, 2019 |
Standard Dates |
| PA-19-056 |
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) |
Jan 5, 2019 |
Standard Dates |
| PA-19-067 |
Processing and Presentation of Non-Conventional MHC Ligands (R01 Clinical Trial Not Allowed) |
Jan 5, 2019 |
Standard Dates |
| PA-19-074 |
Telomeres in Wellness and Disease: A Biobehavioral Approach (R01 Clinical Trial Optional) |
Jan 5, 2019 |
Standard Dates |
| PA-19-080 |
Advancing Development of Rapid Fungal Diagnostics (R01 Clinical Trial Not Allowed) |
Jan 5, 2019 |
Standard Dates |
| PA-19-094 |
Emotion Regulation, Aging and Mental Disorder (R01 Clinical Trial Not Allowed) |
Jan 5, 2019 |
Standard Dates |
| PA-19-112 |
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional) |
Jan 5, 2019 |
Standard Dates |
| PAR-18-919 |
Quantitative Imaging Tools and Methods for Cancer Response Assessment (R01 Clinical Trial Optional) |
Jan 5, 2019 |
Standard Dates |
| PAR-18-930 |
Development and Optimization of Tasks and Measures for Functional Domains of Behavior (R01 Clinical Trial Not Allowed) |
Jan 5, 2019 |
Standard Dates |
| PAR-19-045 |
End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R01 Clinical Trial Optional) |
Jan 5, 2019 |
Standard Dates |
| PAR-19-057 |
Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals (R01 Clinical Trial Optional) |
Jan 5, 2019 |
Standard Dates |
| RFA-MH-19-400 |
BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional) |
Jan 4, 2019 |
Feb 4, 2019;
Oct 9, 2019;
Oct 9, 2020 |
| PA-19-096 |
Control of Sexually Transmitted Infections (STIs) Through a Comprehensive Understanding of the Natural History of Infection (R01 Clinical Trial Not Allowed) |
Jan 4, 2019 |
Standard Dates |
| PAR-19-044 |
End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R21 Clinical Trial Optional) |
Jan 4, 2019 |
Standard Dates |
| PAR-19-078 |
Molecular and Genetic Characterization of Inborn Errors of Immunity (R01 Clinical Trial Not Allowed) |
Jan 4, 2019 |
Standard Dates |
| PAR-19-101 |
Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional) |
Dec 30, 2018 |
Jan 30, 2019;
Jul 30, 2019;
Jan 30, 2020;
Jul 30, 2020 |
| RFA-MH-19-148 |
BRAIN Initiative Cell Census Network (BICCN) Scalable Technologies and Tools for Brain Cell Census (R01 Clinical Trial Not Allowed) |
Dec 22, 2018 |
Jan 22, 2019;
Jan 24, 2020 |
| RFA-MH-19-149 |
BRAIN Initiative Cell Census Network (BICCN) Specialized Collaboratory on Human and Non-Human Primate Brain Cell Atlases (U01 Clinical Trial Not Allowed) |
Dec 22, 2018 |
Jan 22, 2019;
Jan 24, 2020 |
| PAS-18-915 |
HIV/AIDS High Priority Drug Abuse Research (R01 Clinical Trial Optional) |
Dec 7, 2018 |
Standard AIDS Dates |
| PA-18-917 |
Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 – Clinical Trial Optional) |
Dec 7, 2018 |
Standard Dates |
| PA-19-042 |
Engaging Men in HIV Testing, Prevention, and Care (R01 Clinical Trial Optional) |
Dec 7, 2018 |
Standard AIDS Dates |
| PA-19-050 |
Engaging Men in HIV Testing, Prevention, and Care (R21 Clinical Trial Optional) |
Dec 7, 2018 |
Standard AIDS Dates |
| PAR-18-895 |
CNS-Targeted Drug Delivery Strategies for HIV (R01 Clinical Trial Not Allowed) |
Dec 7, 2018 |
Jan 7, 2019;
Jan 7, 2020;
Jan 7, 2021 |
| RFA-MH-19-242 |
Computational Approaches for Validating Dimensional Constructs of Relevance to Psychopathology (R01 Clinical Trial Optional) |
Dec 3, 2018 |
Jan 3, 2019;
Nov 20, 2019;
Nov 20, 2020 |
| PAR-18-884 |
Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R01 – Clinical Trial Not Allowed) |
Nov 4, 2018 |
Dec 4, 2018;
Dec 4, 2019;
Dec 4, 2020 |
| PAR-18-885 |
Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R21 – Clinical Trial Not Allowed) |
Nov 4, 2018 |
Dec 4, 2018;
Dec 4, 2019;
Dec 4, 2020 |
| PAR-18-879 |
Expanding Extramural Research Opportunities at the NIH Clinical Center (U01 Clinical Trial Optional) |
Nov 2, 2018 |
Dec 3, 2018;
Dec 3, 2019;
Dec 3, 2020 |
| PAR-18-929 |
High-Priority Areas for Research Leveraging EHR and Large-Scale Data (R01 Clinical Trial Not Allowed) |
Oct 21, 2018 |
Nov 21, 2018 then Standard dates apply |
| RFA-MH-19-240 |
Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional) |
Oct 20, 2018 |
Nov 20, 2018;
Nov 20, 2019;
Nov 20, 2020; |
| PAR-18-830 |
The Role of Epitranscriptomics in Development and Disease (R01 – Clinical Trial Not Allowed) |
Oct 7, 2018 |
Nov 7, 2018;
Jun 3, 2019;
Mar 3, 2020;
Nov 7, 2020;
Jun 3, 2021 |
| PAR-18-869 |
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) |
Oct 7, 2018 |
Nov 7, 2018;
Mar 6, 2019;
Nov 7, 2019;
Mar 6, 2020 |
| PA-18-718 |
Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R21 Clinical Trial Not Allowed) |
Sep 16, 2018 |
Standard Dates |
| PA-18-824 |
Exploratory Analyses of CALERIE Data and Biospecimens to Elucidate Mechanisms of Caloric Restriction (CR)-Induced Effects in Humans (R21 Clinical Trial Not Allowed) |
Sep 16, 2018 |
Standard Dates |
| PA-18-826 |
Exploratory Analyses of Adherence Strategies and Data Sets from CALERIE to Investigate Behavioral and Psychosocial Aspects of Sustained Caloric Restriction in Humans (R21 Clinical Trial Not Allowed) |
Sep 16, 2018 |
Standard Dates |
| PA-18-839 |
Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R21 Clinical Trial Optional) |
Sep 16, 2018 |
Standard Dates |
| PA-18-850 |
Prevention Research in Mid-Life Adults (R21 Clinical Trial Optional) |
Sep 16, 2018 |
Standard Dates |
| PA-18-858 |
Advancing Research Needed to Develop a Universal Influenza Vaccine (R21 Clinical Trial Not Allowed) |
Sep 16, 2018 |
Standard Dates |
| PA-18-867 |
Novel Approaches for Relating Genetic Variation to Function and Disease (R21 Clinical Trial Not Allowed) |
Sep 16, 2018 |
Standard Dates |
| PA-18-872 |
Research to Advance Vaccine Safety (R21 Clinical Trial Not Allowed) |
Sep 16, 2018 |
Standard Dates |
| PAR-18-788 |
Precision Imaging of Oral Lesions (R21-Clinical Trial Not Allowed) |
Sep 16, 2018 |
Standard Dates |
| PAR-18-857 |
Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed) |
Sep 16, 2018 |
Standard Dates |
| PAR-18-892 |
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional) |
Sep 16, 2018 |
Standard Dates |
| PA-18-719 |
Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R01 Clinical Trial Not Allowed) |
Sep 5, 2018 |
Standard Dates |
| PA-18-776 |
Maternal Nutrition and Pre-pregnancy Obesity: Effects on Mothers, Infants and Children (R01 Clinical Trial Optional) |
Sep 5, 2018 |
Standard Dates |
| PA-18-823 |
Analyses of CALERIE Data and Biospecimens to Elucidate Mechanisms of Caloric Restriction (CR)-Induced Effects in Humans (R01 Clinical Trial Not Allowed) |
Sep 5, 2018 |
Standard Dates |
| PA-18-825 |
Analyses of Adherence Strategies and Data Sets from CALERIE to Explore Behavioral and Psychosocial Aspects of Sustained Caloric Restriction in Humans (R01 Clinical Trial Not Allowed) |
Sep 5, 2018 |
Standard Dates |
| PA-18-838 |
Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R01 Clinical Trial Optional) |
Sep 5, 2018 |
Standard Dates |
| PA-18-849 |
Prevention Research in Mid-Life Adults (R01 Clinical Trial Optional) |
Sep 5, 2018 |
Standard Dates |
| PA-18-856 |
Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed) |
Sep 5, 2018 |
Standard Dates |
| PA-18-859 |
Advancing Research Needed to Develop a Universal Influenza Vaccine (R01 Clinical Trial Not Allowed) |
Sep 5, 2018 |
Standard Dates |
| PA-18-861 |
Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R03 – Clinical Trial Optional) |
Sep 5, 2018 |
Standard Dates |
| PA-18-862 |
Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R21 – Clinical Trial Optional) |
Sep 5, 2018 |
Standard Dates |
| PA-18-863 |
Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R01 – Clinical Trial Optional) |
Sep 5, 2018 |
Standard Dates |
| PA-18-868 |
Novel Approaches for Relating Genetic Variation to Function and Disease (R01 Clinical Trial Not Allowed) |
Sep 5, 2018 |
Standard Dates |
| PA-18-873 |
Research to Advance Vaccine Safety (R01 Clinical Trial Not Allowed) |
Sep 5, 2018 |
Standard Dates |
| PA-18-902 |
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional |
Sep 5, 2018 |
Standard Dates |
| PAR-18-766 |
Identification and Management of Behavioral Symptoms and Mental Health Conditions in Individuals with Intellectual Disabilities (R01 – Clinical Trial Optional) |
Sep 5, 2018 |
Standard Dates |
| PAR-18-787 |
Precision Imaging of Oral Lesions (R01- Clinical Trial Not Allowed) |
Sep 5, 2018 |
Standard Dates |
| PAR-18-820 |
Alzheimer’s Drug-Development Program (U01 Clinical Trial Optional) |
Sep 5, 2018 |
Standard Dates |
| PAR-18-877 |
Early Stage Clinical Trials for the Spectrum of Alzheimer’s Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional) |
Sep 5, 2018 |
Standard Dates |
| PAR-18-878 |
Late Stage Clinical Trials for the Spectrum of Alzheimer’s Disease and Age-related Cognitive Decline (R01 Clinical Trial Required) |
Sep 5, 2018 |
Standard Dates |
| PAR-18-893 |
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional) |
Sep 5, 2018 |
Standard Dates |
| PAR-18-896 |
NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional) |
Sep 5, 2018 |
Standard Dates |
| PAR-18-860 |
Immune Response to Arthropod Blood Feeding (R21 Clinical Trial Not Allowed) |
Sep 4, 2018 |
Oct 15, 2018;
Jun 14, 2019;
Feb 14, 2020;
Oct 15, 2020 |
| PAR-18-777 |
Novel Genomic Technology Development (R01 Clinical Trial Not Allowed) |
Sep 2, 2018 |
Oct 2, 2018;
Oct 2, 2019;
Oct 2, 2020 |
| PAR-18-778 |
Novel Genomic Technology Development, (R21 Clinical Trial Not Allowed) |
Sep 2, 2018 |
Oct 2, 2018;
Oct 2, 2019;
Oct 2, 2020 |
| RFA-MH-19-136 |
BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) |
Aug 27, 2018 |
Sep 27, 2018;
Sep 6, 2019;
Sep 9, 2020 |
| PA-18-753 |
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R01 Clinical Trial Optional) |
Aug 7, 2018 |
Standard AIDS Dates |
| PA-18-754 |
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R21 Clinical Trial Not Allowed) |
Aug 7, 2018 |
Standard AIDS Dates |
| PAR-18-764 |
Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional) |
Aug 7, 2018 |
Standard AIDS Dates |
| PAR-18-822 |
Approaches for Understanding Disease Mechanisms and Improving Outcomes in TB Meningitis (TBM) (R01 Clinical Trial Not Allowed) |
Aug 4, 2018 |
Sep 4, 2018;
Sep 4, 2019;
Sep 4, 2020 |
| PAR-18-789 |
Genetic analysis of non-human animal models to understand the genomic architecture of substance use disorders and addictive behaviors (U01 Clinical Trial Not Allowed) |
Jul 21, 2018 |
Aug 21, 2018;
Mar 19, 2019;
Aug 21, 2019;
Mar 19, 2020;
Aug 21, 2020;
Mar 19, 2021 |
| RFA-MH-19-200 |
Rare Genetic Disorders as a Window into the Genetic Architecture of Mental Disorders (U01 Clinical Trial Not Allowed) |
Jul 9, 2018 |
Aug 9, 2018;
Sep 6, 2019;
Sep 9,2020 |
| RFA-MH-19-201 |
Rare Genetic Disorders as a Window into the Genetic Architecture of Mental Disorders (Collaborative U01 Clinical Trial Not Allowed) |
Jul 9, 2018 |
Aug 9, 2018;
Sep 6, 2019;
Sep 9, 2020 |
| RFA-NS-18-030 |
BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed) |
Jun 3, 2018 |
Jul 3, 2018;
Nov 6, 2018;
Jul 3, 2019;
Nov 6, 2019;
Jul 1, 2020;
Nov 10, 2020 |
| RFA-HG-18-001 |
Novel Nucleic Acid Sequencing Technology Development (R01 Clinical Trial Not Allowed) |
May 27, 2018 |
Jun 27, 2018;
Jun 27, 2019;
Jun 26, 2020 |
| RFA-HG-18-002 |
Novel Nucleic Acid Sequencing Technology Development (R21 Clinical Trial Not Allowed) |
May 27, 2018 |
Jun 27, 2018;
Jun 27, 2019;
Jun 26, 2020 |
| PAR-18-654 |
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) |
May 19, 2018 |
Jun 19, 2018;
Nov 19, 2018;
Jun 18, 2019;
Nov 19, 2019;
Jun 18, 2020;
Nov 19, 2020 |
| PAR-18-655 |
Exploratory/Developmental Grants Program for Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) |
May 19, 2018 |
Jun 19, 2018;
Nov 19, 2018;
Jun 18, 2019;
Nov 19, 2019;
Jun 18, 2020;
Nov 19, 2020 |
| PA-18-571 |
Underactive Bladder and Detrusor Activity in Aging (R03 Clinical Trial Optional) |
May 16, 2018 |
Standard Dates |
| PA-18-572 |
Underactive Bladder and Detrusor Activity in Aging (R21 Clinical Trial Optional) |
May 16, 2018 |
Standard Dates |
| PA-18-602 |
Women & Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21 Clinical Trial Optional) |
May 16, 2018 |
Standard Dates |
| PA-18-620 |
Understanding Processes of Recovery in the Treatment of Alcohol Use Disorder (R21 – Clinical Trial Optional) |
May 16, 2018 |
Standard Dates |
| PA-18-623 |
Tools to Enhance the Study of Prenatal and Pediatric Hydrocephalus (R21 Clinical Trial Not Allowed) |
May 16, 2018 |
Standard Dates |
| PA-18-687 |
Developmental Pharmacodynamics and Models of Drug Effects in Pediatrics (R03 Clinical Trial Optional) |
May 16, 2018 |
Standard Dates |
| PA-18-723 |
Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional) |
May 16, 2018 |
Standard Dates |
| PA-18-724 |
Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development (R21 Clinical Trial Not Allowed) |
May 16, 2018 |
Standard Dates |
| PA-18-728 |
Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional) |
May 16, 2018 |
Standard Dates |
| PA-18-739 |
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional) |
May 16, 2018 |
Standard Dates |
| PA-18-741 |
Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21 Clinical Trial Not Allowed) |
May 16, 2018 |
Standard Dates |
| PAR-18-659 |
Mechanisms of Alcohol Tolerance (R21/R33 Clinical Trial Not Allowed) |
May 16, 2018 |
Standard Dates |
| PAR-18-690 |
Innovative Therapies and Tools for Screenable Disorders in Newborns (R03 Clinical Trial Optional) |
May 16, 2018 |
Standard Dates |
| PAR-18-691 |
Innovative Therapies and Tools for Screenable Disorders in Newborns (R21 Clinical Trial Optional) |
May 16, 2018 |
Standard Dates |
| PAR-18-733 |
Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03 – Clinical Trial Not Allowed) |
May 16, 2018 |
Standard Dates |
| PAR-18-734 |
Small Research Grants for Establishing Basic Science-Clinical Collaborations to Understand Structural Birth Defects (R03 – Clinical Trial Not Allowed) |
May 16, 2018 |
Standard Dates |
| PAR-18-743 |
Pilot and Feasibility Clinical Research Grants in Urologic Disorders (R21 Clinical Trial Optional) |
May 16, 2018 |
Standard Dates |
| PAR-18-744 |
Pilot and Feasibility Clinical Research Grants in Kidney Diseases (R21 Clinical Trial Optional) |
May 16, 2018 |
Standard Dates |
| PAR-18-760 |
In Vivo Synaptic Function in Alzheimer’s Disease and Related Dementias (R21 Clinical Trial Not Allowed) |
May 16, 2018 |
Standard Dates |
| PA-18-773 |
International Research Collaboration on Drug Abuse and Addiction Research |
May 9, 2018 |
Standard Dates |
| PA-18-570 |
Underactive Bladder and Detrusor Activity in Aging (R01 Clinical Trial Optional) |
May 5, 2018 |
Standard Dates |
| PA-18-603 |
Women & Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R01 Clinical Trial Optional) |
May 5, 2018 |
Standard Dates |
| PA-18-619 |
Understanding Processes of Recovery in the Treatment of Alcohol Use Disorder (R01 Clinical Trial Optional) |
May 5, 2018 |
Standard Dates |
| PA-18-622 |
Disease Mechanisms of Prenatal and Pediatric Hydrocephalus (R01 Clinical Trial Not Allowed) |
May 5, 2018 |
Standard Dates |
| PA-18-660 |
Genetics of Alcohol Sensitivity and Tolerance (R01 Clinical Trial Not Allowed) |
May 5, 2018 |
Standard Dates |
| PA-18-688 |
Developmental Pharmacodynamics and Models of Drug Effects in Pediatrics (R01 Clinical Trial Optional) |
May 5, 2018 |
Standard Dates |
| PA-18-722 |
Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional) |
May 5, 2018 |
Standard Dates |
| PA-18-725 |
Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development (R01 Clinical Trial Not Allowed) |
May 5, 2018 |
Standard Dates |
| PA-18-729 |
Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional) |
May 5, 2018 |
Standard Dates |
| PA-18-738 |
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional) |
May 5, 2018 |
Standard Dates |
| PAR-18-616 |
Traceback Testing: Increasing Identification and Genetic Counseling of Mutation Carriers through Family-based Outreach (U01 Clinical Trial Optional) |
May 5, 2018 |
Standard Dates |
| PAR-18-689 |
Innovative Therapies and Tools for Screenable Disorders in Newborns (R01 – Clinical Trial Optional) |
May 5, 2018 |
Standard Dates |
| PAR-18-706 |
Selective Cell and Network Vulnerability in Aging and Alzheimer’s Disease (R01 Clinical Trial Not Allowed) |
May 5, 2018 |
Standard Dates |
| PA-18-615 |
Pilot and Feasibility Studies of HIV and Animal Models for HIV Infection within the Mission of NIDDK (R21 Clinical Trial Optional) |
Apr 7, 2018 |
Standard Dates |
| PA-18-651 |
Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R01 Clinical Trial Optional) |
Apr 7, 2018 |
Standard Dates |
| PA-18-652 |
Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R21 Clinical Trial Not Allowed) |
Apr 7, 2018 |
Standard Dates |
| PA-18-695 |
Basic and Translational Oral Health Research Related to HIV/AIDS (R21 Clinical Trial Not Allowed) |
Apr 7, 2018 |
Standard Dates |
| PA-18-699 |
Basic and Translational Oral Health Research Related to HIV/AIDS (R01 Clinical Trial Not Allowed) |
Apr 7, 2018 |
Standard Dates |
| RFA-EY-18-001 |
BRAIN Initiative: New Concepts and Early – Stage Research for Large – Scale Recording and Modulation in the Nervous System (R21 Clinical Trial Not Allowed) |
Apr 1, 2018 |
May 1, 2018;
Oct 29, 2018;
May 1, 2019;
Oct 29, 2019;
May 1, 2020;
Oct 29, 2020 |
| PAR-18-664 |
Clinical Validation of a Candidate Biomarker for Neurological Disease (U01 Clinical Trial Optional) |
Mar 17, 2018 |
Apr 17, 2018;
Jul 18, 2018;
Feb, 14, 2019;
Jul 18, 2019;
Feb 14, 2020;
Jul 20, 2020 |
| PAR-18-433 |
NIBIB Exploratory/Developmental Research Grant Program (R21 Clinical Trial Optional) |
Jan 25, 2018 |
Standard Dates |
| PA-18-078 |
Neuroscience Research on Drug Abuse (R21 Clinical Trial Optional) |
Jan 17, 2018 |
Standard Dates |
| PA-18-532 |
Early-life Factors and Cancer Development Later in Life (R21 Clinical Trial Not Allowed) |
Jan 16, 2018 |
Standard Dates |
| PA-18-438 |
Hearing Health Care for Adults: Improving Access and Affordability (R01 Clinical Trial Optional) |
Jan 9, 2018 |
Standard Dates |
| PA-18-568 |
International Research Collaboration on Drug Abuse and Addiction Research (R01 Clinical Trial Optional) |
Jan 9, 2018 |
Standard Dates |
| PAR-18-561 |
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U01 Clinical Trial Optional) |
Jan 9, 2018 |
Standard Dates |
| PA-18-060 |
Neuroscience Research on Drug Abuse (R01 Clinical Trial Optional) |
Jan 6, 2018 |
Standard Dates |
| PA-18-377 |
Community Partnerships to Advance Research (CPAR) (R01 Clinical Trial Optional) |
Jan 5, 2018 |
Standard Dates |
| PA-18-569 |
Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R01 Clinical Trial Optional) |
Jan 5, 2018 |
Standard Dates |
| PAS-18-557 |
Research on Comparative Effectiveness and Implementation of HIV/AIDS and Alcohol Interventions (R01 Clinical Trial Optional) |
Jan 5, 2018 |
Standard Dates |
